1946 related articles for article (PubMed ID: 30772227)
1. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
[TBL] [Abstract][Full Text] [Related]
4. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
5. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.
Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783
[TBL] [Abstract][Full Text] [Related]
6. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
[TBL] [Abstract][Full Text] [Related]
7. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
[TBL] [Abstract][Full Text] [Related]
8. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis.
Chin CWL; Everett RJ; Kwiecinski J; Vesey AT; Yeung E; Esson G; Jenkins W; Koo M; Mirsadraee S; White AC; Japp AG; Prasad SK; Semple S; Newby DE; Dweck MR
JACC Cardiovasc Imaging; 2017 Nov; 10(11):1320-1333. PubMed ID: 28017384
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices.
Ito H; Ishida M; Makino W; Goto Y; Ichikawa Y; Kitagawa K; Omori T; Dohi K; Ito M; Sakuma H
J Cardiovasc Magn Reson; 2020 Jun; 22(1):42. PubMed ID: 32498688
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
Kanagala P; Cheng ASH; Singh A; McAdam J; Marsh AM; Arnold JR; Squire IB; Ng LL; McCann GP
J Cardiovasc Magn Reson; 2018 Jan; 20(1):4. PubMed ID: 29321034
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
[TBL] [Abstract][Full Text] [Related]
13. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
[TBL] [Abstract][Full Text] [Related]
14. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Native T
Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
17. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
